ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disparities"

  • Abstract Number: 0674 • ACR Convergence 2021

    A Behavioral Intervention to Improve Gout Outcomes in African Americans with Gout: A 12-month Multicenter, Randomized Controlled Trial

    Jasvinder Singh1, Kenneth Saag1, Joshua Baker2, Amy Joseph3, Seth Eisen4 and Terence Shaneyfelt1, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Pennsylvania, Philadelphia, PA, 3Washington University / St. Louis VA, St Louis, MO, 4Washington University School of Medicine, St Louis, MO

    Background/Purpose: Gout outcomes and severity are worst in African Americans compared to Caucasians with gout. Racial Disparities in gout are well-described. Few or no data…
  • Abstract Number: 0602 • ACR Convergence 2021

    Use of a Popular Opinion Leader Model to Disseminate Information Virtually About Clinical Trial Enrollment to People of Color with Lupus

    Kreager Taber1, Holly Milaeger2, Jessica Williams1, Daniel Erickson3, Elmer Freeman4, Patricia Canessa5, Rosalind Ramsey-Goldman6 and Candace Feldman1, 1Brigham and Women's Hospital, Boston, MA, 2Northwestern University, Feinberg School of Medicine, Chicago, IL, 3Northwestern University, Feinbergy School of Medicine, Chicago, IL, 4CCHERS, Inc., Boston, MA, 5State of Illinois Board of Health, Chicago, IL, 6Northwestern University, Chicago, IL

    Background/Purpose: Despite a disproportionate burden of systemic lupus erythematosus (SLE) and disparities in adverse outcomes among Black compared to white individuals, people of color are…
  • Abstract Number: 0676 • ACR Convergence 2021

    Development, Refinement, and Validation of an Emergency Department Gout Flare Electronic Medical Record Alert

    Lesley Jackson1, Narender Annapureddy2, Kenneth Saag1, James Booth3, Giovanna Rosas1, Jeffrey Foster1, Amy Mudano1, Dongmei Sun4, John Osborne1, Tim Bongartz5, Erik Hess5, Colleen Lawrence6, Leah Dunkel6 and Maria I. Danila1, 1University of Alabama at Birmingham, Birmingham, AL, 2Vanderbilt University Medical Center, Nashville, TN, 3Department of Emergency Medicine, University of Alabama School of Medicine, Birmingham, AL, 4Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, 5Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, 6Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Patients with acute gout are frequently treated in emergency departments (ED) and represent a typically underserved and understudied population. A key limitation of conducting…
  • Abstract Number: 0604 • ACR Convergence 2021

    Disparities in Burden of Disease in Patients with RA Across Racial and Ethnic Groups

    Jacqueline O’Brien1, Sang Hee Park2, Taylor Blachley1, Maya Marchese1, Nicole Middaugh1, Xue Han2, Keith Wittstock2 and Leslie Harrold1, 1CorEvitas, LLC, Waltham, MA, 2Bristol Myers Squibb, Princeton, NJ

    Background/Purpose: Prior research has shown that differences exist in disease activity and clinical outcomes for RA across racial and ethnic groups in the US.1 This…
  • Abstract Number: 0768 • ACR Convergence 2021

    Poverty and Length of Stay in Children Hospitalized with Pediatric Systemic Lupus Erythematosus: An Analysis of the 2016 Kids’ Inpatient Database

    William Soulsby, Erica Lawson and Matthew Pantell, University of California San Francisco, San Francisco, CA

    Background/Purpose: Prior studies have demonstrated alarming health disparities in adult patients with SLE, including higher disease severity and activity among Hispanic and Black patients. Pediatric…
  • Abstract Number: 0605 • ACR Convergence 2021

    Impact of Area of Residence on Perceptions of Health and Disease Activity in Ethnic Minorities with Rheumatoid Arthritis in an Urban Setting

    Mohamed Jalloh1, Sharon Dowell2, Richard Ogunti1 and Gail Kerr3, 1Howard University Internal Medicine Residency, Washington, DC, 2Howard University College of Medicine, Washington, DC, 3Washington D.C., Veterans Affairs Medical Center (VAMC)/Georgetown and Howard Universities, Washington, DC

    Background/Purpose: Health care disparities in hypertension and other chronic disease are well established. Ethnic minority residents of Washington DC, particularly Wards 7 and 8, have…
  • Abstract Number: 0956 • ACR Convergence 2021

    Racial Disparities in Renal Outcomes over Time Among Hospitalized Children with SLE and Effects of Hospital Minority Composition

    Joyce Chang1, Cora Sears2, Veronica Torres3 and Mary Beth Son1, 1Boston Children's Hospital, Brookline, MA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Temple University, Bucks County, PA

    Background/Purpose: Racial and ethnic minorities are disproportionately affected by pediatric-onset SLE and have worse outcomes compared to their white counterparts. With ongoing advances in pediatric…
  • Abstract Number: 0044 • ACR Convergence 2020

    Characterization of Racial Disparities in Rheumatoid Arthritis Treatment Choice and Location of Care

    Elston He1, Eli Cornblath2, Pratyusha Yalamanchi3, Alexis Ogdie2, Joshua Baker2 and Michael George2, 1Synovium, Inc., Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Michigan Medicine, Ann Arbor, MI

    Background/Purpose: Racial disparities in access to care and treatment regimens exist but remain poorly characterized in the rheumatoid arthritis (RA) patient population. Previous studies using…
  • Abstract Number: 0442 • ACR Convergence 2020

    Disparities in CoronaViridae Infection Are Readily Apparent in Rheumatology Patients Despite Use of Hydroxychloquine And/or Methotrexate

    Maria Antonelli1 and Nora Singer2, 1MHMC/CWRU, Cleveland, OH, 2The MetroHealth System, Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: In the initial months of the SARS CoV2/COVID19 pandemic, broad use of off-label therapy with hydroxychloroquine (HCQ) was prescribed to reduce CoV2-related morbidity and…
  • Abstract Number: 0045 • ACR Convergence 2020

    Healthcare Practitioner Confidence Assessing Rashes in Patients of Skin of Color with Lupus

    Vijay Kannuthurai1, Jacob Murray2, Lisa Zickuhr3 and Ling Chen2, 1Washington University in St. Louis School of Medicine, Hazlehurst, MS, 2Washington University in St. Louis School of Medicine, St. Louis, MO, 3Washington University/B-JH/SLCH Consortium, St. Louis, MO

    Background/Purpose: Medical education can promote bias that disproportionately affects patients of color. Patients of color with lupus are especially vulnerable as they often carry a…
  • Abstract Number: 0443 • ACR Convergence 2020

    Impact of the COVID-19 Pandemic on Racial and Ethnic Minority Groups Diagnosed with Rheumatic Diseases

    Emily Sirotich1, Teresa Semalulu1, Kevin Kennedy2, Salman Surangiwala3, Maggie Larche1, Jean Liew4, Mitchell Levine2, Graeme Reed5, Naira Ikram6, Carly Harrison7, Richard Howard8, Rashmi Sinha9, Monique Gore-Massy10 and Jonathan Hausmann11, 1McMaster University, Hamilton, ON, Canada, 2McMaster University, Hamilton, Canada, 3Queen’s School of Medicine, Kingston, Canada, 4University of Washington, Seattle, 5Canadian Spondylitis Association, Vancouver, Canada, 6Duke University, Durham, 7Lupus Chat, NA, 8Spondylitis Association of America, Van Nuys, CA, 9SJIA Foundation, Cincinnati, 10Lupus Foundation of America, Brooklyn, NY, 11Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA

    Background/Purpose: The COVID-19 pandemic has exacerbated structural and systematic barriers in access to healthcare for racial and ethnic minorities. The impact of these increased barriers…
  • Abstract Number: 0046 • ACR Convergence 2020

    Socioeconomic Disparities in Functional Status Among RA Patients: A Longitudinal Analysis Using RISE Data

    Jing Li1, Gabriela Schmajuk2, Michael Evans3, Zara Izadi4, Patricia Katz5, Alexis Ogdie6, Lisa Suter7 and Jinoos Yazdany3, 1University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, Atherton, CA, 3Ucsf, San Francisco, CA, 4University of California San Francisco, San Francisco, CA, 5University of California, San Francisco, Novato, CA, 6Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 7Yale School of Medicine, New Haven, CT

    Background/Purpose: Prior studies have shown that RA outcomes, including disease activity, erosions, and disability, are worse among patients with low socioeconomic status (SES). However, few…
  • Abstract Number: 0574 • ACR Convergence 2020

    Is Hydroxychloroquine Use a Proxy for Health Care Access? Predictors of First Dispensing Among Medicaid Beneficiaries with Incident Lupus

    Katherine Pryor1, Chang Xu1, Jamie Collins1, Karen Costenbader2 and Candace Feldman1, 1Brigham and Women's Hospital, Boston, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Hydroxychloroquine/chloroquine (HCQ/CQ) is considered to be the backbone of systemic lupus erythematosus (SLE) care. Differences in receipt of HCQ/CQ may exacerbate disparities in adverse…
  • Abstract Number: 0047 • ACR Convergence 2020

    Administrative Barriers to Enrollment of Ethnic Minorities in Clinical Research of Rheumatic/Immune-Mediated Diseases

    Brittany Banbury1, Sharon Dowell1, Gail Kerr2, Mercedes Quinones2, Ginette Okoye1 and Ilona Jileaeva1, 1Howard University Hospital, Washington, DC, 2Washington DC VA Medical Center, Washington, DC

    Background/Purpose: Inclusion of ethnic minority subsets in clinical research remains subpar despite mandates for increased participation. Lack of trust, cultural sensitivity and bias, stereotyping, health…
  • Abstract Number: 0575 • ACR Convergence 2020

    The Impact of an Integrated Care Management Program on Acute Care Utilization and Outpatient Appointment Attendance Among High-Risk Patients with Lupus

    Jessica Williams1, Weixing Huang2, Jamie Collins3, Kreager Taber1, Katherine McLaughlin1, Rebecca Cunningham1, Christine Vogeli4, Lisa Wichmann1 and Candace Feldman3, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, 3Brigham and Women's Hospital, Boston, 4Massachusetts General Hospital, Boston, MA

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) are often members of disadvantaged groups and some struggle with high acute care utilization and missed outpatient appointments.…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology